Smt Cardiovascular Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 16-11-2024
- Paid Up Capital ₹ 0.22 M
as on 16-11-2024
- Company Age 5 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 145.14 Cr
as on 16-11-2024
- Revenue 16006.70%
(FY 2023)
- Profit -105.90%
(FY 2023)
- Ebitda 153.67%
(FY 2023)
- Net Worth 170.52%
(FY 2023)
- Total Assets 17.95%
(FY 2023)
About Smt Cardiovascular
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.22 M.
The company currently has active open charges totaling ₹145.14 Cr.
Bhargav Kotadia and Ganesh Sabat serve as directors at the Company.
- CIN/LLPIN
U33302GJ2019PTC110835
- Company No.
110835
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Nov 2019
- Date of AGM
26 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Surat, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Smt Cardiovascular?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ganesh Sabat  | Director | 16-Nov-2019 | Current |
| Bhargav Kotadia | Director | 16-Nov-2019 | Current |
Financial Performance and Corporate Structure Insights of Smt Cardiovascular.
Smt Cardiovascular Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 16006.7% increase. The company also saw a substantial fall in profitability, with a 105.9% decrease in profit. The company's net worth Soared by an impressive increase of 170.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Smt Cardiovascular?
In 2023, Smt Cardiovascular had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vascular Concepts LimitedActive 32 years 6 monthsBhargav Kotadia and Ganesh Sabat are mutual person
Sahajanand Medical Technologies LimitedActive 23 years 2 monthsBhargav Kotadia and Ganesh Sabat are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 15 Apr 2024 | ₹45.14 Cr | Open |
Standard Chartered Bank Creation Date: 13 Apr 2020 | ₹100.00 Cr | Open |
How Many Employees Work at Smt Cardiovascular?
Smt Cardiovascular has a workforce of 104 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Smt Cardiovascular, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Smt Cardiovascular's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
